Advanced Medical Solutions Grp PLC Annual Report and Notice of AGM (1316X)
04 May 2016 - 2:38AM
UK Regulatory
TIDMAMS
RNS Number : 1316X
Advanced Medical Solutions Grp PLC
03 May 2016
3 May 2016
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Annual Report and Accounts for the year ended
31 December 2015 and Notice of AGM
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and wound care markets, is pleased to announce that
in accordance with AIM Rules 20 and 26, the Annual Report and
Financial Statements for the year ended 31 December 2015 were
posted to shareholders today and are available on the Investor
Relations section of the Company's website
http://www.admedsol.com/Investor-Relations
The notice of meeting convening the Annual General Meeting of
the Company, which will be held on 2 June 2016 at 11 a.m. at the
offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP,
was also posted to shareholders today and is available on the
Company's website.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Group Finance Director
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Gary Clarence / Daniel Adams
/ Patrick Robb
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 510 employees. For more
information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUOONRNSAVRAR
(END) Dow Jones Newswires
May 03, 2016 12:38 ET (16:38 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024